279 related articles for article (PubMed ID: 21584831)
1. Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation.
Chan KM; Yu MC; Chou HS; Wu TJ; Lee CF; Lee WC
Ann Surg Oncol; 2011 Sep; 18(9):2638-46. PubMed ID: 21584831
[TBL] [Abstract][Full Text] [Related]
2. Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma.
Ho MH; Yu CY; Chung KP; Chen TW; Chu HC; Lin CK; Hsieh CB
Ann Surg Oncol; 2011 Dec; 18(13):3632-9. PubMed ID: 21626078
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
[TBL] [Abstract][Full Text] [Related]
5. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
[TBL] [Abstract][Full Text] [Related]
6. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
[TBL] [Abstract][Full Text] [Related]
7. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796
[TBL] [Abstract][Full Text] [Related]
8. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
10. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
[TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
[TBL] [Abstract][Full Text] [Related]
12. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
[TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
[TBL] [Abstract][Full Text] [Related]
14. Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.
Kornberg A; Witt U; Matevossian E; Küpper B; Assfalg V; Drzezga A; Hüser N; Wildgruber M; Friess H
PLoS One; 2013; 8(1):e53960. PubMed ID: 23349774
[TBL] [Abstract][Full Text] [Related]
15. The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
Lee DD; Samoylova M; Mehta N; Musto KR; Roberts JP; Yao FY; Harnois DM
Liver Transpl; 2019 Feb; 25(2):228-241. PubMed ID: 30198150
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.
Xu M; Doyle MM; Banan B; Vachharajani N; Wang X; Saad N; Fowler K; Brunt EM; Lin Y; Chapman WC
J Am Coll Surg; 2017 Jul; 225(1):28-40. PubMed ID: 28400300
[TBL] [Abstract][Full Text] [Related]
18. Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol.
Sinha J; Mehta N; Dodge JL; Poltavskiy E; Roberts J; Yao F
Hepatology; 2019 Oct; 70(4):1185-1196. PubMed ID: 30779440
[TBL] [Abstract][Full Text] [Related]
19. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
[TBL] [Abstract][Full Text] [Related]
20. Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients.
Di Benedetto F; Tarantino G; Ercolani G; Baccarani U; Montalti R; De Ruvo N; Berretta M; Adani GL; Zanello M; Tavio M; Cautero N; Tirelli U; Pinna AD; Gerunda GE; Guaraldi G
Oncologist; 2013; 18(5):592-9. PubMed ID: 23666950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
